Service CapabilitiesMolecular Imaging and Analysis
We use molecular imaging techniques such as PET-CT and MRI to scan large animals and accurately obtain pharmacokinetic parameters in vivo. We provide not only the real-time and continuous assessment of disease animal models for diagnosis, disease progression monitoring, and treatment efficacy evaluation, thereby obtaining pharmacodynamic data, but also technical services for new drug development, including molecular radiolabeling synthesis and evaluation of drug targeting and tumor targeting therapeutic effects through animal imaging analysis.
Brain MR And PET imaging of
monkeys (tracer: 18F-FDG)
Whole body PET/CT dynamic imaging of
monkeys
Services Scope
- ⑴ Radiolabeling and Molecular Probe Synthesis: Including isotopes such as124I、89Zr、64Cu、68Ga、18F,etc.
- ⑵ Image Acquisition and Data Analysis: PET/CT image acquisition, MRI/fMRI image acquisition and analysis, PET/MRI image fusion, SUV/SUVR analysis, etc.
- ⑶ Application Scope: PK/PD, ADME, dose range testing, and safety evaluation; assessment of disease animal models, investigation of disease mechanisms; evaluation of drug targeting, etc.
MRI3.0 imaging system of large animals
uMR 770
PET/CT in vivo imaging system of large animals
uBio EXPLORER
